指南与共识妇产影像技术与安全CTMR

宫颈癌近距离治疗CT勾画指南的MRI验证研究

Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy.
指南 / 共识 · Adv Radiat Oncol · 2026-04-01

结果显示CT在HRCTV和IRCTV剂量上与MRI无显著差异;CT高估直肠和乙状结肠体积并低估膀胱2cc和乙状结肠2cc剂量。CT勾画结合诊断期及BT前MRI是安全、便捷的方案。

要点

  • CT勾画时HRCTV与IRCTV剂量无显著差异,可用于BT计划
  • CT会高估乙状结肠和直肠体积,注意OAR剂量评估偏差
  • CT低估膀胱2cc与乙状结肠2cc剂量,报告时需警惕低估风险

核心结论

  • CT勾画在HRCTV和IRCTV剂量学上与MRI无显著差异,结合诊断期和BT前MRI具有安全性及可行性

研究设计与样本

  • 研究时间为2022年4月1日至2023年10月1日,采用根治性放化疗及混合插植近距离治疗
  • 由一名放射肿瘤科医师依据IBS-GEC ESTRO-ABS推荐在BT计划CT上勾画靶区及OAR,并以BT计划MRI为引导

关键影像表现/征象

  • CT高估HRCTV最大宽度、IRCTV点A层面宽度、HRCTV与IRCTV最大厚度(P值分别为<.001、<.001、.049、.007)
  • CT高估乙状结肠和直肠体积,配对差值中位数分别为7.2(IQR 3.1-13.6)和7.8(IQR 3.6-12.8)
  • CT低估膀胱2cc和乙状结肠2cc剂量,配对差值中位数均为0.5(IQR分别为0.3-0.9和0.3-0.8)
  • HRCTV、IRCTV、膀胱、直肠、乙状结肠的Dice相似系数中位数分别为0.72、0.78、0.76、0.68、0.46

诊断标准与关键数值

  • HRCTV最大宽度CT与MRI比较P<.001,IRCTV点A层面宽度P<.001
  • HRCTV最大厚度CT与MRI比较P=.049,IRCTV最大厚度P=.007
  • 乙状结肠体积配对差值中位数7.2(IQR 3.1-13.6),P<.001;直肠体积差值7.8(IQR 3.6-12.8),P=.003
  • 膀胱2cc剂量差值中位数0.5(IQR 0.3-0.9),P<.001;乙状结肠2cc剂量差值0.5(IQR 0.3-0.8),P=.003

临床应用与阅片要点

  • 采用CT勾画行BT计划时,靶区剂量可基本达到与MRI勾画等效
  • 评估直肠、乙状结肠体积及膀胱2cc、乙状结肠2cc剂量时需注意CT的系统性偏差
  • 乙状结肠Dice系数最低(0.46),勾画一致性差,阅片和计划时应重点核对其边界
  • 建议以诊断期MRI和BT前MRI辅助CT勾画,尤其在资源有限机构可作为替代流程

局限性

  • 本研究为单中心数据,样本量52例,Dice系数总体偏低提示勾画一致性有限
  • CT与MRI勾画由一名医师完成,缺乏多观察者一致性评价

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Consensus guidelines from IBS-GEC ESTRO-ABS (Indian Brachytherapy Society- Groupe Européen de Curiethérapie - European Society for Radiotherapy and Oncology- American Brachytherapy Society) for computed tomography (CT)-based contouring have recently introduced possibilities of CT-based adaptive brachytherapy (BT) for cervical cancer. The present study attempts to validate the guidelines by using magnetic resonance imaging (MRI) at diagnosis and in a pre-BT environment.

METHODS AND MATERIALS: The study involved patients with stages IIB to IVA carcinoma of the cervix who had pretreatment MRI and were treated with definitive chemoradiation and hybrid-interstitial BT from April 1, 2022, to October 1, 2023. The target volumes-high-risk clinical target volume (HRCTV), intermediate-risk clinical target volume (IRCTV), and organs-at-risk that included bladder, rectum, and sigmoid-were prospectively delineated on BT planning CT using BT planning MRI for guidance, as per IBS-GEC ESTRO-ABS recommendations by a radiation oncologist. The dimensions, volumes, doses, and Dice similarity coefficient on CT were compared with those on MRI images.

RESULTS: Two hundred eight scans from 104 sets of 52 patients of CT and magnetic resonance scans were the basis for this study. With respect to dimensions, CT overestimated HRCTV maximum width, IRCTV width at point A, and maximum thickness of HRCTV and IRCTV compared with MRI (P values, <.001, <.001, .049, and .007, respectively). In analysis of organs-at-risk volumes, CT overestimated sigmoid and rectum volumes, with median difference of paired values of 7.2 (Interquartile range [IQR], 3.1-13.6) and 7.8 (IQR, 3.6-12.8) and P values of <.001 and .003, respectively. Bladder 2cc and sigmoid 2cc doses were underestimated with CT images, with median difference of paired values of 0.5 (IQR, 0.3-0.9) and 0.5 (IQR, 0.3-0.8) and P values of <.001 and .003, respectively. There was an insignificant difference in HRCTV and IRCTV doses between CT and MR images. The median Dice similarity coefficients of HRCTV, IRCTV, bladder, rectum, and sigmoid were 0.72, 0.78, 0.76, 0.68, and 0.46, respectively.

CONCLUSIONS: Despite the dimensional differences, there was no dosimetric difference in HRCTV and IRCTV. CT-based contouring using IBS-GEC ESTRO-ABS recommendations, with MRI at diagnosis and BT, similar to the MRI at diagnosis + pre-BT MRI + CT at brachytherapy environment, is safe, convenient, and addresses logistic issues in institutions, especially in low- and middle-income countries.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Shinghal, Sanyal, Pradhan, et al. Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy. Adv Radiat Oncol. 2026. PMID: 42294408. doi:10.1016/j.adro.2026.102044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。